MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway.
Moro M, Fortunato O, Bertolini G, Mensah M, Borzi C, Centonze G, Andriani F, Di Paolo D, Perri P, Ponzoni M, Pastorino U, Sozzi G, Boeri M.
Moro M, et al. Among authors: andriani f.
Pharmaceuticals (Basel). 2022 Feb 28;15(3):297. doi: 10.3390/ph15030297.
Pharmaceuticals (Basel). 2022.
PMID: 35337095
Free PMC article.